Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab ZONDA Trial for OCS Reduction in Severe Asthma
NCT02075255Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2014
- Primary completion
- Aug 2016
- Modality
- Monoclonal Antibodies
- Countries
- 12
01
Overview
A Phase 3 trial of benralizumab in asthma, sponsored by AstraZeneca. Started Apr 2014; status: completed.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02075255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02075255.